Source link : https://www.newshealth.biz/health-news/should-intensified-infliximab-for-refractory-acute-severe-uc-be-nixed/
Intensified or accelerated dosing regimens with infliximab (Remicade) did not improve outcomes compared with the standard regimen in patients with steroid-refractory acute severe ulcerative colitis undergoing rescue therapy, the randomized PREDICT-UC trial showed. In 138 adult patients randomized to a first dose of 10 mg/kg or 5 mg/kg, there was no significant difference in the […]
Author : News Health
Publish date : 2024-09-06 14:57:14
Copyright for syndicated content belongs to the linked Source.
